Setting the Stage: Clinical Innovation from Boston and Beyond
Tuesday, February 01, 2022
7:00 PM - 8:30 PM
Add to Calendar
Eastern Standard Time
Please join us for the first in our three-part series that is focused on introducing HBA members to the evolution of the life sciences industry over the past 20 years, and the leading role that Boston has played in it. Starting with The Human Genome Project, the latest cutting-edge innovations in genetic editing, precision medicines and AI all contribute to advancing the development of treatments for chronic and rare diseases. This series of HBA programs will explore what has driven the great strides made in therapeutic and disease advancement as well as how to adapt to the realities and dynamics of clinical development today.
In this first event, explore the history from genetics to gene therapy in this fireside chat, moderated by Taren Grom, Editor in Chief Emeritus of Pharma Voice. Bob Coughlin, Managing Director of JLL's National Life Science Practice, and Wendy White, Board Member of ICHORD and former Chief Patent Officer of Vitrisa Therapeutics, will discuss the drivers and inspiration behind the clinical innovation that is needed to bring these inventive and life-changing therapies to patients.